This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.
RSV Infection
This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
-
Advanced Specialty Research, Boise, Idaho, United States, 83702
Saint Alphonsus Regional Medical Center, Boise, Idaho, United States, 83706
St. Luke's Boise Medical Center, Boise, Idaho, United States, 83712
Clinical Research Prime, Idaho Falls, Idaho, United States, 83404
Saint Alphonsus Medical Center, Nampa, Idaho, United States, 83687
St. Luke's Nampa Medical Center, Nampa, Idaho, United States, 83687
Velocity Clinical Research - New Orleans, New Orleans, Louisiana, United States, 70119
Velocity Clinical Research, Gulfport, Gulfport, Mississippi, United States, 39503
Boeson Research GTF, Great Falls, Montana, United States, 59405
OBGYN Associates, Great Falls, Montana, United States, 59405
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
0 Years to
ALL
Yes
Pfizer,
Pfizer CT.gov Call Center, STUDY_DIRECTOR, Pfizer
2028-02-24